# Use of Elamipretide in patients assigned treatment in the compassionate use program: Case series in pediatric patients with rare orphan diseases.

> PubMed lists PMID 36636586 in JIMD reports as Journal Article, with publication-date metadata of 2022-09-21 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-36636586-elamipretide:v1`
- Evidence domain: Literature metadata
- Date in source: 2023-08-15
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-36636586-elamipretide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-36636586-elamipretide-v1.json
- Content SHA-256: `677db810e73c433f88517a1d49cd5a275160106c1a2d1b78e4f0a70cac520beb`

## Claims and source pins

### Headline

Use of Elamipretide in patients assigned treatment in the compassionate use program: Case series in pediatric patients with rare orphan diseases. ([`pubmed-observation-pmid-36636586-2023-08-15-e16bd31c7efe`](#source-pubmed-observation-pmid-36636586-2023-08-15-e16bd31c7efe))

### Summary

PubMed lists PMID 36636586 in JIMD reports as Journal Article, with publication-date metadata of 2022-09-21 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36636586-2023-08-15-e16bd31c7efe`](#source-pubmed-observation-pmid-36636586-2023-08-15-e16bd31c7efe))

### Paragraph 1

PubMed lists PMID 36636586 in JIMD reports as Journal Article, with publication-date metadata of 2022-09-21 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-36636586-2023-08-15-e16bd31c7efe`](#source-pubmed-observation-pmid-36636586-2023-08-15-e16bd31c7efe))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-36636586-2023-08-15-e16bd31c7efe`](#source-pubmed-observation-pmid-36636586-2023-08-15-e16bd31c7efe))

## Sources

<a id="source-pubmed-observation-pmid-36636586-2023-08-15-e16bd31c7efe"></a>
- **Use of Elamipretide in patients assigned treatment in the compassionate use program: Case series in pediatric patients with rare orphan diseases. · retained source version 1:2023-08-15:current:e16bd31c7efe85af39f6925d450be2c40995adc030ee26b5f59976caa2b3241f** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/36636586/) (`pubmed-observation-pmid-36636586-2023-08-15-e16bd31c7efe`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Use of Elamipretide in patients assigned treatment in the compassionate use program: Case series in pediatric patients with rare orphan diseases." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-36636586-elamipretide-v1.json SHA-256: 677db810e73c433f88517a1d49cd5a275160106c1a2d1b78e4f0a70cac520beb.